MoneyWorks4Me

Lactose India - Quaterly Results

09 Aug 2022 Evaluate
The revenue zoomed 12.06% to Rs. 96.24 millions for the quarter ended June 2022 as compared to Rs. 85.88 millions during the corresponding quarter last year.The Total Profit for the quarter ended June 2022 of Rs. 0.87 millions grew from Rs.-6.54 millionsOperating profit for the quarter ended June 2022 rose to 25.08 millions as compared to 15.25 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 96.24 85.88 12.06 96.24 85.88 12.06 459.39 349.63 31.39
Other Income 2.25 0.69 226.09 2.25 0.69 226.09 5.80 3.13 85.30
PBIDT 25.08 15.25 64.46 25.08 15.25 64.46 128.41 65.35 96.50
Interest 12.41 13.60 -8.75 12.41 13.60 -8.75 51.16 54.48 -6.09
PBDT 12.67 1.65 667.88 12.67 1.65 667.88 77.25 10.87 610.67
Depreciation 11.60 10.74 8.01 11.60 10.74 8.01 45.59 43.58 4.61
PBT 1.07 -9.09 -111.77 1.07 -9.09 -111.77 31.66 -32.71 -196.79
TAX 0.20 -2.55 -107.84 0.20 -2.55 -107.84 7.16 -7.93 -190.29
Deferred Tax 0.10 -2.55 -103.92 0.10 -2.55 -103.92 1.46 -8.42 -117.34
PAT 0.87 -6.54 -113.30 0.87 -6.54 -113.30 24.50 -24.78 -198.87
Equity 125.89 114.37 10.07 125.89 114.37 10.07 125.89 114.37 10.07
PBIDTM(%) 26.06 17.76 46.76 26.06 17.76 46.76 27.95 18.69 49.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..